Duke Creighton 12/9/24 Duke Creighton 12/9/24

NIH invites UN&UP to present its transformative TheraLode™ technology at the 2025 International Stroke Conference (ISC).

NIH invites UN&UP to present its transformative TheraLode™ technology at the 2025 International Stroke Conference (ISC)

Duke Creighton 12/2/24 Duke Creighton 12/2/24

UN&UP Announces Collaboration with MagCorp™ on Florida Polytechnic Capstone Design Team

UN&UP proudly secured first place at the NIH Blueprint MedTech Summit, gaining funding, and support to advance groundbreaking medical devices toward commercialization.

Duke Creighton 11/18/24 Duke Creighton 11/18/24

UN&UP Announces its second Biomedical Engineering Design Team for Fall 2024

Welcome Our Senior Design Team for Fall 2024!

Duke Creighton 11/4/24 Duke Creighton 11/4/24

UN&UP Announces Support for its Fall ‘2024 Biomedical Engineering Design Teams

Welcome Our Senior Design Team for Fall 2024!

Duke Creighton 10/21/24 Duke Creighton 10/21/24

UN&UP Takes First Place at NIH Blueprint MedTech Seedling Summit.

UN&UP proudly secured first place at the NIH Blueprint MedTech Summit, gaining funding, and support to advance groundbreaking medical devices toward commercialization.

Duke Creighton 10/7/24 Duke Creighton 10/7/24

UN&UP selected by the NIH to present its transformative TheraLode™ thrombolysis platform at RESI-Boston

Anna Potter-Malone 3/25/24 Anna Potter-Malone 3/25/24

Un&Up Awarded NIH Diversity Supplements for Miss Gabrielle Vander Vinne

Anna Potter-Malone 1/29/24 Anna Potter-Malone 1/29/24

Un&Up Awarded Two NIH Diversity Supplements for Ms. Kellan Moore and Mr. Matthew De Venecia

Anna Potter-Malone 12/18/23 Anna Potter-Malone 12/18/23

UN&UP Promotes Nick Jensen to Director of Science & Robotics and Matt De Venecia to Project Engineer

We’re excited to announce the promotion of two internal team members here at Un&Up!

Duke Creighton 12/4/23 Duke Creighton 12/4/23

UN&UP Selected to Present at BIOTECH SHOWCASE in San Francisco during JPM Conference

Duke Creighton 11/29/23 Duke Creighton 11/29/23

UN&UP One of Only 17 Companies Awarded a Blueprint MedTech Cycle I Award for its Novel Thrombolysis Platform for Acute Ischemic Stroke

UN&UP is one of only 17 Companies Awarded a Blueprint MedTech Cycle I Award for its Novel Thrombolysis Platform for Acute Ischemic Stroke

Duke Creighton 10/2/23 Duke Creighton 10/2/23

UN&UP Promotes Leah Morrell to Director of Product Management

UN&UP is thrilled to announce the promotion of Leah Morrell from Product Manager to Director of Product Management

Duke Creighton 9/25/23 Duke Creighton 9/25/23

UN&UP’s Transformational CorBot™ Electrophysiology System was Awarded Participation into the Prestigious C3i Program by the NIBIB, NHLBI, and Coulter Foundation

UN&UP’s transformational CorBot™ electrophysiology system was awarded participation into the prestigious C3i program by the NIBIB, NHLBI, and Coulter Foundation

Duke Creighton 8/28/23 Duke Creighton 8/28/23

UN&UP’s TheraLode™ nanoparticle thrombolysis platform for acute ischemic stroke selected to be part of the NIH’s Company Showcase at Life Science Summit

Un&Up’s TheraLode™ nanoparticle thrombolysis platform for acute ischemic stroke has been selected to be part of the NIH’s Emerging Company Showcase at the Life Science Summit in New York City!

Duke Creighton 8/14/23 Duke Creighton 8/14/23

UN&UP Announces the Newest Member of our Fellowship Program: Matthew DeVenecia

It’s with great excitement that we welcome Matthew DeVenecia to the team!

Guest User 7/24/23 Guest User 7/24/23

UN&UP Featured in the St. Louis INNO Chapter of The Business Journals for Efforts to Advance Stroke Treatment

We are honored to be featured in the most recent edition of St. Louis INNO’s chapter of The Business Journal.

Guest User 7/10/23 Guest User 7/10/23

UN&UP Receives Another Prestigious NIH Phase II SBIR Award from the NINDS for its Novel TheraLode™ Thrombolysis Platform

We are thrilled to share that UN&UP has been awarded its largest NIH Phase II SBIR award yet from the NINDS for developing our innovative TheraLode™ thrombolysis pharmaceutical platform for acute ischemic stroke.